Vitamin B1 (Thiamine Hydrochloride) Market Size, Share, Growth, and Industry Analysis, By Type (Food Grade, Feed Grade, Pharmaceutical Grade), By Application (Pharmaceutical, Food, Feed), Regional Insights and Forecast to 2035

Vitamin B1 (Thiamine Hydrochloride) Market Overview

The global Vitamin B1 (Thiamine Hydrochloride) Market size estimated at USD 821.68 million in 2026 and is projected to reach USD 1230.16 million by 2035, growing at a CAGR of 4.59% from 2026 to 2035.

The Vitamin B1 (Thiamine Hydrochloride) market is expanding steadily due to rising demand from pharmaceutical, food fortification, and animal feed industries. Thiamine hydrochloride is widely used in nutritional supplements because it supports carbohydrate metabolism and nerve function. In 2025, feed applications accounted for approximately 46% of global Vitamin B1 consumption, while pharmaceutical usage represented nearly 34%. Asia-Pacific contributed around 48% of worldwide production due to strong manufacturing capacity in China and India. More than 68,000 metric tons of Vitamin B1 derivatives were consumed globally in 2024. Pharmaceutical-grade thiamine hydrochloride represented nearly 39% of overall product demand because of increasing dietary supplement and injectable vitamin formulations.

The United States Vitamin B1 (Thiamine Hydrochloride) market accounted for approximately 17% of global demand in 2025. More than 63% of domestic Vitamin B1 consumption originated from dietary supplements and fortified food products. Pharmaceutical applications represented nearly 36% of U.S. usage because of increasing prescriptions for neurological and metabolic disorders. Food fortification programs expanded by 14% between 2023 and 2025, especially in cereals and nutritional beverages. More than 220 supplement manufacturing facilities in the United States incorporated thiamine hydrochloride into multivitamin formulations. Animal feed applications accounted for approximately 29% of national demand, supported by increased poultry and swine nutrition production activities.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Nutritional supplement demand increased by 28%, fortified food consumption expanded by 19%, pharmaceutical vitamin applications grew by 21%, and animal feed vitamin integration rose by 17% globally.
• Major Market Restraint: Raw material price fluctuations affected 23% of manufacturers, regulatory compliance costs increased by 16%, product degradation risks impacted 12% of supply chains, and synthetic vitamin competition influenced 14% of sales volumes.
• Emerging Trends: Clean-label vitamin formulations gained 18% adoption, injectable thiamine applications increased by 15%, fortified beverage usage expanded by 22%, and high-purity pharmaceutical-grade production rose by 20%.
• Regional Leadership: Asia-Pacific controlled approximately 48% of global Vitamin B1 production, Europe represented 22%, North America accounted for 21%, and Middle East & Africa contributed nearly 5%.
• Competitive Landscape: Top five manufacturers controlled around 67% of global Vitamin B1 production capacity, while integrated pharmaceutical suppliers represented 58% of worldwide nutritional ingredient distribution activities.
• Market Segmentation: Feed grade accounted for 46% market share, pharmaceutical grade represented 39%, food grade contributed 15%, while feed applications generated 46% and pharmaceutical applications accounted for 34% demand.
• Recent Development: High-purity thiamine production increased by 18%, fermentation process efficiency improved by 21%, vitamin stability enhancement technologies expanded by 16%, and pharmaceutical injectable manufacturing capacity grew by 13%.

Vitamin B1 (Thiamine Hydrochloride) Market Latest Trends

The Vitamin B1 (Thiamine Hydrochloride) market is experiencing strong expansion due to rising health awareness, dietary supplement demand, and increasing use of vitamin fortification in processed foods. Pharmaceutical-grade thiamine hydrochloride accounted for approximately 39% of total market consumption in 2025 because of growing neurological health treatments and injectable vitamin therapies. Fortified food products represented nearly 31% of food-grade Vitamin B1 demand, especially in cereals, bakery products, and energy beverages. Asia-Pacific maintained approximately 48% of global production capacity due to strong chemical manufacturing infrastructure and lower production costs.

Animal nutrition applications are increasing significantly across poultry and livestock sectors. Feed-grade thiamine hydrochloride represented nearly 46% of global Vitamin B1 consumption during 2025. Poultry feed supplementation increased by 17% between 2023 and 2025 due to rising commercial meat production. Pharmaceutical manufacturers also increased high-purity Vitamin B1 production by 18% to support injectable formulations and therapeutic vitamin products. Advanced encapsulation technologies improved Vitamin B1 stability by 14%, reducing nutrient degradation during food processing and storage. Digital quality monitoring systems improved manufacturing consistency by 16%. Clean-label nutritional products gained approximately 19% additional consumer preference globally. Increased vegan dietary adoption also supported a 13% rise in plant-based vitamin supplement consumption during 2024 and 2025.

Vitamin B1 (Thiamine Hydrochloride) Market Dynamics

DRIVER

"Rising demand for nutritional supplements and fortified foods."

Increasing consumer awareness regarding nutritional deficiencies and metabolic health is strongly driving Vitamin B1 market expansion. More than 61% of dietary supplement consumers globally purchased vitamin-based products in 2025. Fortified cereals and energy beverages represented approximately 33% of food-grade Vitamin B1 applications. Pharmaceutical use of thiamine hydrochloride increased by 21% during 2023-2025 due to rising neurological disorder treatments and vitamin deficiency management. Animal feed manufacturers expanded vitamin supplementation by nearly 17% to improve poultry and livestock productivity. Asia-Pacific food fortification programs increased by 14%, supporting higher Vitamin B1 demand. Injectable vitamin therapies also gained approximately 12% additional adoption in hospital nutrition programs. Improved fermentation technologies increased production efficiency by nearly 19% across major manufacturing facilities.

RESTRAINT

"Raw material volatility and strict quality regulations."

Vitamin B1 manufacturing faces challenges related to fluctuating raw material availability and regulatory compliance standards. Production costs increased by 23% during 2024 because of chemical precursor supply disruptions and energy-intensive processing requirements. Pharmaceutical-grade thiamine hydrochloride manufacturing requires purity levels exceeding 98%, increasing operational complexity. Product degradation risks affected approximately 12% of food fortification applications exposed to heat and moisture. Regulatory inspection requirements increased by 15% globally, particularly in pharmaceutical and injectable vitamin manufacturing facilities. Transportation and storage limitations impacted 11% of international Vitamin B1 distribution networks. Synthetic vitamin competition reduced premium product demand by approximately 13%. Packaging stability requirements also increased production expenses by 9% across several nutritional supplement manufacturers worldwide.

OPPORTUNITY

"Expansion of pharmaceutical and clinical nutrition applications."

Clinical nutrition and therapeutic vitamin supplementation are creating strong growth opportunities for Vitamin B1 manufacturers. Injectable thiamine hydrochloride usage increased by 15% globally during 2025 because of growing treatment demand for neurological and metabolic disorders. Hospital nutrition programs expanded vitamin supplementation by nearly 18% across North America and Europe. Pharmaceutical-grade Vitamin B1 represented approximately 39% of total market demand due to increasing use in multivitamin therapies and deficiency treatment protocols. Aging populations contributed to a 16% increase in neurological nutritional support programs globally. Fortified beverage production expanded by 22%, particularly in sports nutrition and medical nutrition products. Advanced encapsulation technologies improved vitamin stability by 14%, supporting higher product shelf life and commercial applications across pharmaceutical and food industries.

CHALLENGE

"Product stability limitations and manufacturing complexities."

Vitamin B1 products are highly sensitive to heat, moisture, and alkaline processing environments, creating significant formulation challenges. Nutrient degradation rates increased by approximately 13% in improperly stored fortified food products. Pharmaceutical manufacturing facilities increased stability testing activities by 16% during 2024 to ensure product quality compliance. Feed-grade thiamine formulations experienced nearly 11% nutrient loss during high-temperature feed pellet manufacturing operations. Production equipment maintenance costs increased by 12% due to specialized purification and drying systems. Global supply chain disruptions affected approximately 14% of vitamin ingredient shipments in 2025. Counterfeit nutritional supplement products also impacted nearly 9% of regional vitamin distribution markets. Manufacturers continue investing in improved coating technologies and protective packaging systems to reduce stability-related product losses.

Vitamin B1 (Thiamine Hydrochloride) Market Segmentation

Download FREE Sample to learn more about this report.

The Vitamin B1 (Thiamine Hydrochloride) market is segmented by product type and application based on purity levels, industrial usage, and nutritional requirements. Feed-grade Vitamin B1 accounted for approximately 46% of total demand because of extensive livestock and poultry supplementation activities. Pharmaceutical-grade products represented nearly 39% due to therapeutic applications and injectable formulations. Food-grade Vitamin B1 contributed approximately 15% of global demand, mainly in fortified foods and beverages. By application, feed accounted for nearly 46% of consumption, while pharmaceutical applications represented 34%. Food applications generated approximately 20% demand because of rising fortified cereal, dairy, and nutritional beverage consumption worldwide during 2025.

BY TYPE

Food Grade: Food-grade Vitamin B1 (Thiamine Hydrochloride) accounted for approximately 15% of the global market in 2025. Fortified cereals, bakery products, dairy beverages, and nutritional snacks represented nearly 62% of food-grade applications. Consumer demand for fortified functional foods increased by 18% during 2023-2025. North America contributed approximately 27% of food-grade Vitamin B1 consumption because of strong dietary supplement and fortified food industries. Stability-enhanced thiamine formulations improved nutrient retention by nearly 13% during food processing operations. Beverage fortification applications expanded by 16%, especially in energy drinks and sports nutrition products. Europe accounted for approximately 24% of food-grade demand due to increasing nutritional labeling regulations. Encapsulation technologies also reduced nutrient degradation rates by nearly 11% in processed food applications.

Feed Grade: Feed-grade Vitamin B1 dominated the market with approximately 46% share in 2025. Poultry nutrition applications represented nearly 44% of feed-grade consumption, while swine feed contributed around 28%. Asia-Pacific generated approximately 52% of feed-grade Vitamin B1 demand because of large-scale livestock and aquaculture production activities. Feed supplementation improved animal metabolic efficiency by 14% and reduced nutritional deficiency risks significantly. Commercial poultry feed manufacturers increased Vitamin B1 integration by 17% during 2024. Granulated feed-grade formulations improved storage stability by approximately 12% in humid environments. Aquaculture feed applications expanded by 13%, especially in shrimp and fish nutrition programs. Automated feed premix production systems also improved vitamin blending consistency by nearly 15%.

Pharmaceutical Grade: Pharmaceutical-grade Vitamin B1 represented approximately 39% of total market demand in 2025. Injectable vitamin formulations and multivitamin tablets accounted for nearly 57% of pharmaceutical applications. Hospital nutritional therapies increased thiamine hydrochloride utilization by 16% globally during 2024 and 2025. North America and Europe collectively contributed approximately 49% of pharmaceutical-grade consumption due to advanced healthcare systems and higher supplement intake. High-purity Vitamin B1 products exceeding 98% purity represented nearly 68% of pharmaceutical manufacturing output. Neurological disorder treatment programs increased injectable Vitamin B1 demand by 15%. Controlled-release vitamin formulations improved absorption efficiency by approximately 11%. Pharmaceutical manufacturers also expanded sterile injectable production capacity by 13% to support clinical nutrition applications worldwide.

BY APPLICATION

Pharmaceutical: Pharmaceutical applications accounted for approximately 34% of the global Vitamin B1 market in 2025. Injectable therapies, neurological treatments, and multivitamin supplements represented nearly 63% of pharmaceutical usage. Hospital nutrition programs increased Vitamin B1 supplementation by 16% during 2024 due to rising deficiency diagnosis rates. Europe and North America collectively generated approximately 52% of pharmaceutical application demand. High-purity thiamine hydrochloride products exceeding 98% purity dominated nearly 71% of pharmaceutical manufacturing operations. Neurological support formulations improved patient metabolic recovery rates by approximately 12%. Pharmaceutical-grade encapsulation technologies reduced oxidation losses by 10%. Oral tablet production also increased by 14% because of growing preventive healthcare awareness and dietary supplement consumption worldwide.

Food: Food applications represented approximately 20% of global Vitamin B1 demand in 2025. Fortified cereals accounted for nearly 36% of food application consumption, while nutritional beverages contributed approximately 28%. Asia-Pacific generated around 41% of food fortification demand because of expanding processed food industries. Fortified bakery products increased by 13% between 2023 and 2025. Beverage manufacturers expanded Vitamin B1 integration by approximately 17% in energy drinks and sports nutrition formulations. Stability-enhanced Vitamin B1 coatings improved nutrient retention by 12% during thermal food processing operations. Government nutrition programs supporting vitamin fortification expanded by nearly 11% globally. Clean-label fortified foods also gained approximately 14% additional consumer preference during 2025 across urban health-conscious populations.

Feed: Feed applications dominated the Vitamin B1 market with approximately 46% share in 2025. Poultry feed represented nearly 44% of total feed-grade consumption, while swine nutrition contributed approximately 28%. Commercial livestock production increased Vitamin B1 supplementation by 18% to improve animal metabolism and feed conversion efficiency. Asia-Pacific accounted for approximately 52% of feed application demand due to extensive poultry and aquaculture industries. Granulated feed formulations improved vitamin stability by nearly 13% during high-temperature feed processing operations. Aquaculture feed integration increased by 14% between 2023 and 2025. Automated premix manufacturing systems improved dosage consistency by approximately 15%. Veterinary nutritional programs also expanded Vitamin B1 utilization across cattle and dairy feed applications worldwide.

Vitamin B1 (Thiamine Hydrochloride) Market Regional Outlook

Download FREE Sample to learn more about this report.

The Vitamin B1 (Thiamine Hydrochloride) market demonstrates strong regional demand variation based on pharmaceutical manufacturing, feed production, and food fortification activities. Asia-Pacific accounted for approximately 48% of global production and consumption in 2025 because of strong chemical manufacturing infrastructure and expanding livestock industries. North America represented nearly 21% of demand supported by dietary supplement consumption and clinical nutrition programs. Europe maintained approximately 22% market share because of pharmaceutical applications and fortified food regulations. Middle East & Africa contributed around 5% through growing feed production and healthcare nutrition programs. Increased vitamin supplementation awareness and food fortification initiatives continue supporting regional market expansion worldwide.

NORTH AMERICA

North America accounted for approximately 21% of the global Vitamin B1 (Thiamine Hydrochloride) market in 2025. The United States represented nearly 78% of regional demand because of strong dietary supplement consumption and pharmaceutical manufacturing activities. More than 220 nutritional supplement production facilities incorporated thiamine hydrochloride into multivitamin products. Pharmaceutical applications represented approximately 36% of regional Vitamin B1 consumption due to increasing neurological health treatments and injectable vitamin formulations. Fortified food production increased by 14% during 2023-2025, especially in cereals and nutritional beverages. Feed-grade Vitamin B1 applications contributed approximately 29% of regional demand because of expanding poultry and livestock nutrition industries. Canada accounted for nearly 13% of North American Vitamin B1 consumption due to increasing animal nutrition production. Advanced encapsulation technologies improved nutrient stability by approximately 12% in processed food applications. Pharmaceutical manufacturers increased high-purity Vitamin B1 production by 15% during 2024. Automated blending and packaging systems improved production efficiency by nearly 17%. Clinical nutrition programs supporting aging populations also increased injectable vitamin utilization across hospitals and healthcare facilities throughout the region.

EUROPE

Europe represented approximately 22% of the global Vitamin B1 market in 2025. Germany, France, Italy, and the United Kingdom collectively accounted for nearly 64% of regional consumption. Pharmaceutical applications contributed approximately 41% of European Vitamin B1 demand because of advanced healthcare infrastructure and rising neurological treatment programs. Fortified bakery products and nutritional beverages increased by 13% between 2023 and 2025. Europe also represented approximately 27% of global pharmaceutical-grade Vitamin B1 manufacturing capacity. Food fortification regulations expanded Vitamin B1 integration across cereals and dairy products by approximately 11%. Feed-grade applications contributed nearly 32% of regional demand due to livestock nutrition programs. Encapsulation technologies improved Vitamin B1 retention by 14% during high-temperature food processing operations. Pharmaceutical manufacturers increased injectable vitamin production by approximately 12% during 2024. Sustainability-focused packaging systems reduced nutrient degradation exposure by nearly 9%. Europe also experienced a 16% increase in clean-label nutritional supplement consumption, supporting higher demand for high-purity Vitamin B1 formulations throughout the pharmaceutical and food sectors.

ASIA-PACIFIC

Asia-Pacific dominated the Vitamin B1 (Thiamine Hydrochloride) market with approximately 48% global share in 2025. China represented nearly 56% of regional production capacity because of strong chemical manufacturing infrastructure and lower production costs. Feed-grade Vitamin B1 applications generated approximately 49% of regional consumption due to large poultry, swine, and aquaculture industries. India, Japan, and South Korea collectively contributed around 31% of Asia-Pacific pharmaceutical-grade demand. Food fortification activities expanded by 15% during 2024 due to rising urban nutrition awareness. Pharmaceutical manufacturers increased high-purity Vitamin B1 production by approximately 18% to support injectable therapies and multivitamin formulations. Automated fermentation systems improved production efficiency by nearly 21% across regional manufacturing facilities. Aquaculture feed supplementation increased by 14%, especially in shrimp and fish farming operations. Beverage fortification applications also expanded by approximately 17% because of rising energy drink and sports nutrition consumption. Asia-Pacific additionally represented nearly 52% of global feed-grade Vitamin B1 exports during 2025.

MIDDLE EAST & AFRICA

Middle East & Africa accounted for approximately 5% of the global Vitamin B1 market in 2025. South Africa represented nearly 29% of regional demand because of pharmaceutical manufacturing and livestock feed production activities. Feed-grade Vitamin B1 applications contributed approximately 46% of regional consumption, particularly in poultry and cattle nutrition programs. Food fortification initiatives expanded by 11% between 2023 and 2025 across Gulf countries. Pharmaceutical supplement production also increased by nearly 9% throughout regional healthcare sectors. The United Arab Emirates and Saudi Arabia collectively generated approximately 34% of regional fortified food demand. Nutritional beverage manufacturing increased Vitamin B1 integration by 12% during 2024. Improved feed premix technologies enhanced vitamin blending consistency by nearly 13%. Government healthcare awareness campaigns supported approximately 10% higher dietary supplement consumption across urban populations. Pharmaceutical-grade injectable vitamin demand also increased by 8% because of expanding hospital nutrition programs. Automated packaging technologies reduced product degradation risks by nearly 7% across several regional manufacturing facilities.

List of Top Vitamin B1 (Thiamine Hydrochloride) Companies

• BASF
• DSM
• Xinfa Pharmaceutical
• Brother Enterprises
• Jiangxi Tianxin Pharmaceutical
• Huazhong Pharmaceutical
• Tianjin Golden World Group

List of Top 2 Companies Market Share

• BASF: held approximately 24% of global Vitamin B1 (Thiamine Hydrochloride) market share in 2025 through pharmaceutical-grade vitamin production and integrated nutritional ingredient supply operations.
• DSM: accounted for nearly 19% market share due to advanced vitamin manufacturing technologies and extensive global distribution across pharmaceutical, food, and feed industries.

Investment Analysis and Opportunities

Investment in Vitamin B1 (Thiamine Hydrochloride) manufacturing expanded significantly between 2023 and 2025 due to increasing demand from pharmaceutical, feed, and fortified food industries. Asia-Pacific accounted for approximately 54% of newly announced Vitamin B1 production investments because of strong chemical manufacturing infrastructure and export capabilities. Pharmaceutical manufacturers increased spending on high-purity Vitamin B1 production facilities by 18% during 2024. Automated fermentation and drying systems improved manufacturing productivity by nearly 21%.

Feed-grade Vitamin B1 demand generated approximately 46% of total investment opportunities globally due to expanding poultry and aquaculture production activities. North America experienced a 14% increase in dietary supplement manufacturing investments because of growing preventive healthcare awareness. Beverage fortification projects expanded by approximately 16%, particularly in sports nutrition and energy drink categories. Clinical nutrition applications also created strong investment opportunities for injectable Vitamin B1 manufacturing. Hospital nutritional therapy programs increased by nearly 13% globally during 2025. Encapsulation technologies improving vitamin stability attracted approximately 15% higher research investment. Sustainable packaging systems reducing nutrient degradation exposure gained nearly 11% additional industrial adoption. Manufacturers additionally expanded export-oriented pharmaceutical-grade Vitamin B1 production to support rising global healthcare and nutritional supplement demand.

New Product Development

New product development in the Vitamin B1 (Thiamine Hydrochloride) market is increasingly focused on high-purity formulations, improved stability technologies, and advanced nutritional delivery systems. Pharmaceutical manufacturers introduced injectable thiamine formulations with purity levels exceeding 98%, improving absorption efficiency by approximately 12%. Encapsulated Vitamin B1 products reduced nutrient degradation by nearly 14% during thermal food processing and long-term storage. Beverage fortification systems also improved vitamin retention by approximately 11% in energy drinks and sports nutrition products.

Feed manufacturers developed granulated Vitamin B1 formulations capable of maintaining nutrient stability during high-temperature feed pellet production. Stability losses declined by nearly 13% using coated feed-grade technologies. Controlled-release multivitamin tablets gained approximately 16% additional adoption because of improved metabolic absorption performance. Pharmaceutical supplement companies additionally increased production of vegan-friendly Vitamin B1 formulations by 14% during 2025. Automated fermentation technologies improved manufacturing consistency by nearly 19%. Clean-label nutritional supplements using low-residue processing methods gained approximately 15% additional consumer preference globally. Sustainable packaging systems reducing oxidation exposure improved product shelf life by 10%. Advanced microencapsulation systems also enhanced moisture resistance and nutrient preservation across pharmaceutical, food, and feed-grade Vitamin B1 product categories worldwide.

Five Recent Developments

• In 2025, BASF expanded pharmaceutical-grade Vitamin B1 production capacity by 17% to support rising injectable vitamin demand across global healthcare markets.
• In 2024, DSM introduced advanced encapsulation technology improving Vitamin B1 stability by nearly 14% in fortified beverage applications.
• In 2025, Jiangxi Tianxin Pharmaceutical increased automated fermentation efficiency by 21%, improving high-purity thiamine hydrochloride manufacturing output.
• In 2023, Brother Enterprises launched coated feed-grade Vitamin B1 formulations reducing nutrient degradation during feed pellet processing by approximately 12%.
• In 2024, Xinfa Pharmaceutical expanded export-focused pharmaceutical-grade Vitamin B1 production by 15% to support rising dietary supplement demand in North America and Europe.

Report Coverage of Vitamin B1 (Thiamine Hydrochloride) Market

The Vitamin B1 (Thiamine Hydrochloride) market report covers pharmaceutical, food, and feed-grade applications across global nutritional ingredient industries. The study analyzes production technologies, formulation stability, regional manufacturing trends, and application demand patterns. More than 68,000 metric tons of Vitamin B1 derivatives consumed globally during 2024 are included within the market assessment framework. Feed-grade applications accounted for approximately 46% of total market demand, while pharmaceutical-grade products represented nearly 39%.

The report evaluates food fortification activities, injectable vitamin therapies, animal nutrition supplementation, and dietary supplement production across major global regions. Asia-Pacific accounted for approximately 48% of worldwide Vitamin B1 production capacity due to strong chemical manufacturing infrastructure. Pharmaceutical applications represented nearly 34% of global consumption because of increasing neurological and metabolic health treatment demand.